Next Article in Journal
Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
Next Article in Special Issue
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
Previous Article in Journal
Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells
Open AccessArticle

Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

1
Brain Cancer Research Unit & Leukaemia Foundation Research Unit, Queensland Institute of Medical Research, Brisbane, QLD 4006, Australia
2
Queensland Brain Institute, University of Queensland, Brisbane, QLD 4067, Australia
3
Kenneth G. Jamieson Department of Neurosurgery, Royal Brisbane and Women's Hospital, Brisbane, QLD 4024, Australia
4
Cancer Services, Royal Brisbane and Women's Hospital, Brisbane, QLD 4024, Australia
5
Pathology Department, Royal Brisbane and Women's Hospital, Brisbane, QLD 4024, Australia
6
Oncogenic Signalling Laboratory, Centre for Cancer Research, Monash Institute of Medical Research, Melbourne, VIC 3168, Australia
7
Department of Medicine, University of Queensland, Brisbane, QLD 4006, Australia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2013, 5(2), 357-371; https://doi.org/10.3390/cancers5020357
Received: 18 February 2013 / Revised: 18 March 2013 / Accepted: 22 March 2013 / Published: 3 April 2013
(This article belongs to the Special Issue Glioblastoma)
Brain cancer research has been hampered by a paucity of viable clinical tissue of sufficient quality and quantity for experimental research. This has driven researchers to rely heavily on long term cultured cells which no longer represent the cancers from which they were derived. Resection of brain tumors, particularly at the interface between normal and tumorigenic tissue, can be carried out using an ultrasonic surgical aspirator (CUSA) that deposits liquid (blood and irrigation fluid) and resected tissue into a sterile bottle for disposal. To determine the utility of CUSA-derived glioma tissue for experimental research, we collected 48 CUSA specimen bottles from glioma patients and analyzed both the solid tissue fragments and dissociated tumor cells suspended in the liquid waste fraction. We investigated if these fractions would be useful for analyzing tumor heterogeneity, using IHC and multi-parameter flow cytometry; we also assessed culture generation and orthotopic xenograft potential. Both cell sources proved to be an abundant, highly viable source of live tumor cells for cytometric analysis, animal studies and in-vitro studies. Our findings demonstrate that CUSA tissue represents an abundant viable source to conduct experimental research and to carry out diagnostic analyses by flow cytometry or other molecular diagnostic procedures. View Full-Text
Keywords: glioblastoma; glioma; brain cancer; CUSA; surgical aspirate; multiplex flow cytometric analysis; brain cancer stem cells; tumor heterogeneity glioblastoma; glioma; brain cancer; CUSA; surgical aspirate; multiplex flow cytometric analysis; brain cancer stem cells; tumor heterogeneity
Show Figures

Figure 1

MDPI and ACS Style

Day, B.W.; Stringer, B.W.; Wilson, J.; Jeffree, R.L.; Jamieson, P.R.; Ensbey, K.S.; Bruce, Z.C.; Inglis, P.; Allan, S.; Winter, C.; Tollesson, G.; Campbell, S.; Lucas, P.; Findlay, W.; Kadrian, D.; Johnson, D.; Robertson, T.; Johns, T.G.; Bartlett, P.F.; Osborne, G.W.; Boyd, A.W. Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research. Cancers 2013, 5, 357-371.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop